AmCyte Company
AmCyte develops encapsulated proliferated human islets for transplantation into patients with diabetes. The company specializes in adult stem cell research to treat diabetes with islet replacement therapy.
Technology:
Regenerative Medicine
Industry:
Transplants
Headquarters:
United States
Founded Date:
1991-01-01
Funding Status:
M&A
Register and Claim Ownership